Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Tenax Therapeutics, Inc. Tenax Therapeutics Hosting Key Opinion Leader Webinar on TNX-201: A Potential Treatment for Pulmonary Arterial Hypertension (PAH) May 25, 2022 From Tenax Therapeutics, Inc. Via Business Wire Tickers TENX Tenax Therapeutics Announces Successful Comparative Pharmacokinetic Study of TNX-201 for the Treatment of Pulmonary Arterial Hypertension May 23, 2022 From Tenax Therapeutics, Inc. Via Business Wire Tickers TENX Tenax Therapeutics Announces $8 Million PIPE Offering Priced At-the-Market under Nasdaq Rules May 18, 2022 From Tenax Therapeutics, Inc. Via Business Wire Tickers TENX Tenax Therapeutics Reports Fiscal Year 2021 Results and Provides Business Update March 31, 2022 From Tenax Therapeutics, Inc. Via Business Wire Tickers TENX Tenax Therapeutics Announces Two Presentations at Upcoming American College of Cardiology Scientific Sessions March 30, 2022 From Tenax Therapeutics, Inc. Via Business Wire Tickers TENX Tenax Therapeutics Reports Third Quarter 2021 Results and Provides Business Update November 16, 2021 From Tenax Therapeutics, Inc. Via Business Wire Tickers TENX Tenax Therapeutics Announces Clearance of the Investigational New Drug Application for Imatinib in Pulmonary Arterial Hypertension (PAH) October 06, 2021 From Tenax Therapeutics, Inc. Via Business Wire Tickers TENX Tenax Therapeutics to Present at the Benzinga Healthcare Small Cap Conference September 28, 2021 From Tenax Therapeutics, Inc. Via Business Wire Tickers TENX Tenax Therapeutics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference September 09, 2021 From Tenax Therapeutics, Inc. Via Business Wire Tickers TENX Tenax Therapeutics Reports Second Quarter 2021 Results and Provides Business Update August 17, 2021 From Tenax Therapeutics, Inc. Via Business Wire Tickers TENX Tenax Announces New Publication Highlighting Novel Levosimendan Mechanism of Action in Pulmonary Hypertension Patients with Heart Failure and Preserved Ejection Fraction (PH-HFpEF) August 12, 2021 From Tenax Therapeutics, Inc. Via Business Wire Tickers TENX Tenax Therapeutics Announced KOL Webinar on Levosimendan for Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF) August 05, 2021 From Tenax Therapeutics, Inc. Via Business Wire Tickers TENX Tenax Therapeutics Announces CEO Transition and $10 Million PIPE Offering Priced At-the-Market under Nasdaq Rules July 07, 2021 From Tenax Therapeutics, Inc. Via Business Wire Tickers TENX Tenax Therapeutics Set to Join Russell Microcap® Index June 10, 2021 From Tenax Therapeutics, Inc. Via Business Wire Tickers TENX Tenax Therapeutics Reports First Quarter 2021 Results and Provides Business Update May 17, 2021 From Tenax Therapeutics, Inc. Via Business Wire Tickers TENX Tenax Announces Publication Titled “Levosimendan Improves Hemodynamics and Exercise Tolerance in PH-HFpEF: Results of the Randomized Placebo-Controlled HELP Trial ” April 09, 2021 From Tenax Therapeutics, Inc. Via Business Wire Tickers TENX Tenax Therapeutics Announces Continuation of Board Refreshment Program as Three Long-Serving Directors Volunteer to Not Stand for Re-Election at the Upcoming 2021 Annual Meeting of Stockholders April 07, 2021 From Tenax Therapeutics, Inc. Via Business Wire Tickers TENX Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.